Truxima 100 mg/10 mL (10 mg/mL) single-dose vial Images

Generic Name: rituximab

This medication has been identified as Truxima 100 mg/10 mL (10 mg/mL) single-dose vial. It is supplied by Teva Pharmaceuticals USA, Inc.

Truxima is used in the treatment of Follicular Lymphoma; Granulomatosis with Polyangiitis; Chronic Lymphocytic Leukemia; Microscopic Polyangiitis; Non-Hodgkin's Lymphoma and belongs to the drug class CD20 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Truxima 100 mg/10 mL (10 mg/mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Truxima

Generic Name

rituximab

Strength

100 mg/10 mL (10 mg/mL) single-dose vial

Availability

Prescription only

Drug Class

CD20 monoclonal antibodies

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Teva Pharmaceuticals USA, Inc.

Manufacturer

Cephalon, Inc.

National Drug Code (NDC)

63459-0103

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer